THE ROLE OF GLYCEMIA VARIABILITY IN THE PROCESSES OF CELLULAR AND VASCULAR AGEING IN PATIENTS WITH TYPE 2 DIABETES

Aim. To investigate  on  the  presence and  relation characteristics of glycemia  variability (GV) and   vascular   wall  parameters,  chronic inflammation, oxidation status,   telomere  biology in type  2  diabetes patients (DM2).Material and methods. Into the single-movement study, 50 DM2 patients...

Full description

Bibliographic Details
Main Authors: E. N. Dudinskaya, N. V. Brailova, О. N. Tkacheva, I. D. Strajesko, N. V. Sharashkina, О. Yu. Isaykina, I. N. Ozerova, D. А. Skvortsov, D. P. Vasilkova, S. А. Boytsov, M. V. Shestakova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2017-06-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/576
id doaj-137fdb0ed1e240bf9ecb8798596fef28
record_format Article
spelling doaj-137fdb0ed1e240bf9ecb8798596fef282021-07-28T13:51:01Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252017-06-01163394510.15829/1728-8800-2017-3-39-45452THE ROLE OF GLYCEMIA VARIABILITY IN THE PROCESSES OF CELLULAR AND VASCULAR AGEING IN PATIENTS WITH TYPE 2 DIABETESE. N. Dudinskaya0N. V. Brailova1О. N. Tkacheva2I. D. Strajesko3N. V. Sharashkina4О. Yu. Isaykina5I. N. Ozerova6D. А. Skvortsov7D. P. Vasilkova8S. А. Boytsov9M. V. Shestakova10N. I. Pirogov Russian National Research Medical University (RNRMU) — SD “Russian Gerontological Scientific-Clinical Center”N. I. Pirogov Russian National Research Medical University (RNRMU) — SD “Russian Gerontological Scientific-Clinical Center”N. I. Pirogov Russian National Research Medical University (RNRMU) — SD “Russian Gerontological Scientific-Clinical Center”; National Research Center for Preventive Medicine of the Ministry of HealthNational Research Center for Preventive Medicine of the Ministry of HealthN. I. Pirogov Russian National Research Medical University (RNRMU) — SD “Russian Gerontological Scientific-Clinical Center”National Research Center for Preventive Medicine of the Ministry of HealthNational Research Center for Preventive Medicine of the Ministry of HealthLomonosov Moscow State UniversityLomonosov Moscow State UniversityRussian Cardiological Research-and-Production Complex of the Ministry of HealthFSBI Endocrinology Scientific Center of the Ministry of HealthAim. To investigate  on  the  presence and  relation characteristics of glycemia  variability (GV) and   vascular   wall  parameters,  chronic inflammation, oxidation status,   telomere  biology in type  2  diabetes patients (DM2).Material and methods. Into the single-movement study, 50 DM2 patients included, with no signs of cardiovascular diseases. All participants  were evaluated on the carbohydrate  metabolism, glycemia variablity, underwent duplex  scan   of  carotid   arteries   with  intima-media  complex  (IMC) measurement, and  assessment for atherosclerotic  plaques;  underwent carotid-femoral pulse wave velocity measurement, endothelium dependent vasodialtion, telomere length measurement and telomerase activity (TA).Results. The parameters of vessel wall, together with the classical CVD risk  factors,   independently   related   with the  various  carbohydrate metabolism parameters: glycated hemoglobin, fasting glucose plasma, HOMA-IR index, C-peptide, immune reactive insulin. The GV of moderate amplitude  of glycemia (MAGE) was related  to IMC increase  in DM2 patients.  There was significant relation of telomere length (TL) not just with a chronic hyperglycemia, but with glucose level fluctuations as well, e.g. with GV standard deviation (SD), MAGE, CONGA (continuous overall net glycemic action), and such relation is higher in the analysis of “the longest”  telomeres.  Relation of TL  and  GV  is not dependent on the cardiovascular risk factors,  chronic inflammation and TA, but depends on fasting plasma glucose.  There was no significant relation of TA with GV in DM2. There was direct correlation of GV CONGA  and oxidative stress marker malonic dialdehyde, and independent negative correlation of GV (MAGE, SD, CONGA) with TL.Conclusion. GV is related  with subclinical atherosclerosis (IMC) and shorter  TL in DM2 patients,  which is mediated  by activated oxidation stress under glycemia fluctuations.https://cardiovascular.elpub.ru/jour/article/view/576glycemia variabilitytelomere lengthvascular ageingdiabetes mellitustelomerase activity
collection DOAJ
language Russian
format Article
sources DOAJ
author E. N. Dudinskaya
N. V. Brailova
О. N. Tkacheva
I. D. Strajesko
N. V. Sharashkina
О. Yu. Isaykina
I. N. Ozerova
D. А. Skvortsov
D. P. Vasilkova
S. А. Boytsov
M. V. Shestakova
spellingShingle E. N. Dudinskaya
N. V. Brailova
О. N. Tkacheva
I. D. Strajesko
N. V. Sharashkina
О. Yu. Isaykina
I. N. Ozerova
D. А. Skvortsov
D. P. Vasilkova
S. А. Boytsov
M. V. Shestakova
THE ROLE OF GLYCEMIA VARIABILITY IN THE PROCESSES OF CELLULAR AND VASCULAR AGEING IN PATIENTS WITH TYPE 2 DIABETES
Кардиоваскулярная терапия и профилактика
glycemia variability
telomere length
vascular ageing
diabetes mellitus
telomerase activity
author_facet E. N. Dudinskaya
N. V. Brailova
О. N. Tkacheva
I. D. Strajesko
N. V. Sharashkina
О. Yu. Isaykina
I. N. Ozerova
D. А. Skvortsov
D. P. Vasilkova
S. А. Boytsov
M. V. Shestakova
author_sort E. N. Dudinskaya
title THE ROLE OF GLYCEMIA VARIABILITY IN THE PROCESSES OF CELLULAR AND VASCULAR AGEING IN PATIENTS WITH TYPE 2 DIABETES
title_short THE ROLE OF GLYCEMIA VARIABILITY IN THE PROCESSES OF CELLULAR AND VASCULAR AGEING IN PATIENTS WITH TYPE 2 DIABETES
title_full THE ROLE OF GLYCEMIA VARIABILITY IN THE PROCESSES OF CELLULAR AND VASCULAR AGEING IN PATIENTS WITH TYPE 2 DIABETES
title_fullStr THE ROLE OF GLYCEMIA VARIABILITY IN THE PROCESSES OF CELLULAR AND VASCULAR AGEING IN PATIENTS WITH TYPE 2 DIABETES
title_full_unstemmed THE ROLE OF GLYCEMIA VARIABILITY IN THE PROCESSES OF CELLULAR AND VASCULAR AGEING IN PATIENTS WITH TYPE 2 DIABETES
title_sort role of glycemia variability in the processes of cellular and vascular ageing in patients with type 2 diabetes
publisher «SILICEA-POLIGRAF» LLC
series Кардиоваскулярная терапия и профилактика
issn 1728-8800
2619-0125
publishDate 2017-06-01
description Aim. To investigate  on  the  presence and  relation characteristics of glycemia  variability (GV) and   vascular   wall  parameters,  chronic inflammation, oxidation status,   telomere  biology in type  2  diabetes patients (DM2).Material and methods. Into the single-movement study, 50 DM2 patients included, with no signs of cardiovascular diseases. All participants  were evaluated on the carbohydrate  metabolism, glycemia variablity, underwent duplex  scan   of  carotid   arteries   with  intima-media  complex  (IMC) measurement, and  assessment for atherosclerotic  plaques;  underwent carotid-femoral pulse wave velocity measurement, endothelium dependent vasodialtion, telomere length measurement and telomerase activity (TA).Results. The parameters of vessel wall, together with the classical CVD risk  factors,   independently   related   with the  various  carbohydrate metabolism parameters: glycated hemoglobin, fasting glucose plasma, HOMA-IR index, C-peptide, immune reactive insulin. The GV of moderate amplitude  of glycemia (MAGE) was related  to IMC increase  in DM2 patients.  There was significant relation of telomere length (TL) not just with a chronic hyperglycemia, but with glucose level fluctuations as well, e.g. with GV standard deviation (SD), MAGE, CONGA (continuous overall net glycemic action), and such relation is higher in the analysis of “the longest”  telomeres.  Relation of TL  and  GV  is not dependent on the cardiovascular risk factors,  chronic inflammation and TA, but depends on fasting plasma glucose.  There was no significant relation of TA with GV in DM2. There was direct correlation of GV CONGA  and oxidative stress marker malonic dialdehyde, and independent negative correlation of GV (MAGE, SD, CONGA) with TL.Conclusion. GV is related  with subclinical atherosclerosis (IMC) and shorter  TL in DM2 patients,  which is mediated  by activated oxidation stress under glycemia fluctuations.
topic glycemia variability
telomere length
vascular ageing
diabetes mellitus
telomerase activity
url https://cardiovascular.elpub.ru/jour/article/view/576
work_keys_str_mv AT endudinskaya theroleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT nvbrailova theroleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT ontkacheva theroleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT idstrajesko theroleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT nvsharashkina theroleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT oyuisaykina theroleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT inozerova theroleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT daskvortsov theroleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT dpvasilkova theroleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT saboytsov theroleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT mvshestakova theroleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT endudinskaya roleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT nvbrailova roleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT ontkacheva roleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT idstrajesko roleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT nvsharashkina roleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT oyuisaykina roleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT inozerova roleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT daskvortsov roleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT dpvasilkova roleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT saboytsov roleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
AT mvshestakova roleofglycemiavariabilityintheprocessesofcellularandvascularageinginpatientswithtype2diabetes
_version_ 1721270846710874112